Hayon Igal Louria serves as Executive at Raphael Pharmaceutical Inc., where they oversee executive responsibilities. Since joining the company, Hayon Igal Louria has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 29, 2023 involved exercising options for 999,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 29, 2023 | RAPH | $0 | Exercise | 999,000 | $N/A | Discretionary |
Hayon Igal Louria currently holds 999,000 shares of Raphael Pharmaceutical Inc. (RAPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hayon Igal Louria has been a net neutral trader of RAPH stock. They have purchased $0 and sold $0 worth of shares.
Hayon Igal Louria's most recent insider trade was on Aug 29, 2023, when they sold 999,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted